Mindray Medical International Ltd’s (MR) share price has entered into oversold territory with an RSI value of 28.7. The Zacks Consensus Estimate for Mindray for the full year period has improved 2 cents over the past two months to $2.14 per share. Currently, Mindray has a Zacks Rank #2 (Buy), suggesting that now might be a good time to get in on (MR) after its recent drop.
MINDRAY MEDICAL INTL LTD (MR): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies